{
    "name": "evinacumab",
    "comment": "Rx",
    "other_names": [
        "Evkeeza",
        "evinacumab-dgnb"
    ],
    "classes": [
        "Lipid-Lowering Agents",
        "ANGPTL Inhibitors"
    ],
    "source": "https://reference.medscape.com/drug/evkeeza-evinacumab-4000135",
    "pregnancy": {
        "common": [
            "Based on animal studies, may cause fetal harm",
            "Consider pregnancy testing in females who may become pregnant before starting treatment",
            "Available human data are insufficient to evaluate for a drug-associated risk of major birth defects, miscarriage, or adverse maternal or fetal outcomes",
            "Evinacumab is a human IgG4 monoclonal antibody, and human IgG is known to cross the placental barrier; therefore, evinacumab may potentially transmit from mother to developing fetus",
            "Advise pregnant females of potential fetal risk ",
            "If patient becomes pregnant during treatment, report exposure by calling 1-833-385-3392"
        ],
        "specific": [
            {
                "type": "Animal data",
                "description": [
                    "SC administration to pregnant rabbits during organogenesis resulted in fetal malformations (domed head, hydrocephalus, and flexed limbs) at doses below the maximum recommended human dose",
                    "These malformations were not observed in pregnant rats"
                ]
            },
            {
                "type": "Contraception",
                "description": [
                    "Females of reproductive potential should use effective contraception during treatment and for at least 5 months following last dose"
                ]
            }
        ]
    },
    "lactation": {
        "common": [
            "Data are unavailable regarding presence in human milk or animal milk, effects on breastfed infants, or effects on milk production",
            "Maternal IgG is known to be present in human milk; effects of local gastrointestinal exposure and limited systemic exposure in breastfed infants are unknown "
        ]
    },
    "warnings": {
        "black_box_warning": {
            "common": [],
            "specific": []
        },
        "contraindicators": {
            "common": [
                "History of serious hypersensitivity to drug or any of its excipients"
            ],
            "specific": []
        },
        "cautions": {
            "common": [
                "Serious hypersensitivity reactions, including anaphylaxis, reported; if serious reaction occurs, discontinue infusion and treat according to standard of care",
                "May cause fetal harm based on animal reproduction studies "
            ],
            "specific": []
        }
    },
    "interactions": [],
    "adverse effects": [
        {
            "name": "Nasopharyngitis",
            "percent": "16"
        },
        {
            "name": "Influenzalike illness",
            "percent": "7"
        },
        {
            "name": "Infusion",
            "percent": "7"
        },
        {
            "name": "related reactions",
            "percent": "6"
        },
        {
            "name": "Dizziness",
            "percent": "5"
        },
        {
            "name": "Rhinorrhea",
            "percent": "5"
        },
        {
            "name": "Nausea",
            "percent": "4"
        },
        {
            "name": "Pain in extremity",
            "percent": "4"
        },
        {
            "name": "Asthenia",
            "percent": "3"
        },
        {
            "name": "Constipation",
            "percent": "3"
        },
        {
            "name": "Upper respiratory tract infection",
            "percent": "3"
        },
        {
            "name": "Nasal congestion",
            "percent": "3"
        },
        {
            "name": "Abdominal pain",
            "percent": "1"
        },
        {
            "name": "Serious anaphylaxis",
            "percent": null
        },
        {
            "name": "Decreased diastolic blood pressure",
            "percent": null
        },
        {
            "name": "transient",
            "percent": null
        },
        {
            "name": "mild",
            "percent": null
        },
        {
            "name": "to",
            "percent": null
        },
        {
            "name": "moderate",
            "percent": null
        },
        {
            "name": "Increased heart rate",
            "percent": null
        }
    ]
}